Silke Schelenz
- Infectious Diseases top 0.5%
- Antifungal resistance and susceptibility 44
- Antimicrobial Resistance in Staphylococcus 7
- Epidemiology top 2%
- Fungal Infections and Studies 26
- Pneumocystis jirovecii pneumonia detection and treatment 8
- Infective Endocarditis Diagnosis and Management 6
- Nail Diseases and Treatments 5
- Microbiology top 2%
- Clinical Biochemistry top 2%
-
- Cystic Fibrosis Research Advances 9
-
- Antibiotic Resistance in Bacteria 6
- Co-authors
- Darius Armstrong‐JamesAlireza AbdolrasouliElizabeth M. JohnsonColin BrownAndrew M. BormanJacques F. MeisAnuradha ChowdharyMatthew C. Fisher
- Journals
- Journal of Antimicrobial Chemotherapy (5 papers)Medical Mycology (4 papers)Journal of Hospital Infection (4 papers)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
Silke Schelenz
66 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Infectious Diseases 2.1k
- Applied Microbiology and Biotechnology 195
- Epidemiology 1.6k
- Microbiology 195
- Clinical Biochemistry 171
Countries citing papers authored by Silke Schelenz
This map shows the geographic impact of Silke Schelenz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silke Schelenz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silke Schelenz more than expected).
Fields of papers citing papers by Silke Schelenz
This network shows the impact of papers produced by Silke Schelenz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silke Schelenz. The network helps show where Silke Schelenz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Silke Schelenz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2022 | 3 | |
| 4 | 2021 | 3 | |
| 5 | 2020 | 6 | |
| 6 | 2020 | 1 | |
| 7 | 2020 | 42 | |
| 8 | 2019 | 78 | |
| 9 | 2019 | 45 | |
| 10 | 2018 | 14 | |
| 11 | 2018 | 37 | |
| 12 | 2016 | 9 | |
| 13 | 2015 | 41 | |
| 14 | 2015 | 130 | |
| 15 | 2015 | 17 | |
| 16 | 2011 | 39 | |
| 17 | 2010 | 74 | |
| 18 | 2007 | 13 | |
| 19 | 2003 | 76 | |
| 20 | 2003 | 45 |
About Silke Schelenz
Silke Schelenz is a scholar working on Infectious Diseases, Applied Microbiology and Biotechnology and Microbiology, having authored 75 papers that have together received 2.9k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (44 papers), Fungal Infections and Studies (26 papers), Cystic Fibrosis Research Advances (9 papers), Pneumocystis jirovecii pneumonia detection and treatment (8 papers), Antimicrobial Resistance in Staphylococcus (7 papers), Antibiotic Resistance in Bacteria (6 papers), Infective Endocarditis Diagnosis and Management (6 papers) and Nail Diseases and Treatments (5 papers). The work is most often cited by research in Infectious Diseases (2.1k citations), Applied Microbiology and Biotechnology (195 citations) and Epidemiology (1.6k citations). Silke Schelenz has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Darius Armstrong‐James, Alireza Abdolrasouli, Elizabeth M. Johnson, Colin Brown, Andrew M. Borman, Jacques F. Meis, Anuradha Chowdhary, Matthew C. Fisher, Johanna Rhodes and Rohini Manuel. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Medical Mycology, Journal of Hospital Infection, Journal of Infection and Mycoses.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.